RSA Conference Booth #1039 - The Cloud Security Alliance (CSA), the world's leading organization dedicated to defining and raising awareness of best practices to help ensure a secure cloud...

Trovagene, Inc. (NASDAQ: TROV), a clinical-stage oncology therapeutics company, developing targeted therapeutics for the treatment of hematologic and solid tumor cancers, today announced the...

Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today reported preliminary data from the Toca 6 Phase 1 trial of Toca 511 & Toca FC in advanced solid tumors...

Aprea Therapeutics today presented results at the 2018 AACR Annual Meeting from its ongoing Phase Ib/II clinical study in MDS. The ongoing study, sponsored by the Moffitt Cancer Center with...

Beginning May 2nd in Amberes (Belgium) while May 4th he will visit Stockholm (Sweden). These presentations will set a start of Ismael Cala's world tour with the conference "The business of being...